Insomnia Treatment Market Global Trends, Market Share, Industry Size, Growth, Opportunities, and Market Forecast 2019 to 2029 Global insomnia treatment market to value over USD 5.8 Billion by 2029 end and register a CAGR of over 5.2% from 2019 to 2029. The growing cases of insomnia worldwide due to rising stress levels has led to the growth of this market. With rising geriatric population coupled with awareness about numerous therapies and treatments in the market, support and propel the market’s growth. With advancements in technology and invention of better, efficient, new therapies providing quick, positive results, the public is more open to accepting such cures. Thus the increase in the launch of novel products such as Merck & Co.’s Belsomra is projected to fuel high demand. Moreover, the availability of multiple generics is expected to boost the insomnia therapeutics market over the forecast period. Lemborexant, a novel Orexin Receptor Antagonist (ORA) by Eisai is expected to be launched in the near future, which may promote growth. With new products and technology employed the market is estimated to soar unboundedly. Additionally, quite a few medical devices have been approved in the recent years such as EBB Insomnia Therapy, Fisher Wallace Stimulator, and AlphaStim AID, which are expected to have higher penetration due to favourable reimbursement policies and adoption of the device-drug combination therapies for treating insomnia. North America was leading the insomnia therapeutics market and accounted for a major revenue share. Favourable reimbursement policies will further promote revenue growth. North America is followed by the Asia Pacific, which is poised to grow at healthy CAGR. Emerging economies such as India, China, and Indonesia have been using generics and branded generics due to the economic pricing of generic alternatives. Asia Pacific is anticipated to witness lucrative growth over the forecast period with a high CAGR. The global insomnia therapeutics market is highly fragmented with several manufacturers offering generics. Major market players are Takeda Pharmaceutical Company Ltd.; Vanda Pharmaceuticals; Merck & Co., Inc.; Pfizer Inc.; Teva Pharmaceutical Industries Ltd.; Mylan N.V.; Sumitomo Dainippon Pharma Co., Ltd; Sanofi; Paratek Pharmaceuticals Inc.; and Ebb Therapeutics. Major strategies are novel drug development and technological advances in medical devices are expected to boost competition in this market. Request a Sample Report @ https://www.futurewiseresearch.com/requestsample.aspx?id=258&page=requestsample Global Insomnia Treatment Market: Segmentation By Drug Type • OTC Drugs • OTC Sleep Aids • OTC Sleep Supplements • Prescription Drugs By Distribution Channel • Hospital Pharmacies • Retail Pharmacies • e-Commerce • Drug Stores • Others By Region: • Europe • North America • APAC • Latin America • Rest of World Purchase a Copy & Ask For Discount: https://www.futurewiseresearch.com/requestsample.aspx?id=258&page=askfordiscount Competitive Landscape: • Tier 1 players- established companies in the market with a major market share • Tier 2 players • Emerging players which are growing rapidly • New Entrants FutureWise Takeaways • Growth prospects • SWOT analysis • Key trends • Key data points affecting market growth Objectives of the Study: • To provide an exhaustive analysis on the global insomnia treatment market by drug type, by distribution channel and by region • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints) • To evaluate and forecast micro-markets and the overall market • To predict the market size, in key regions (along with countries)—North America, Europe, Asia Pacific, Latin America, and the Middle East. • To record evaluate and competitive landscape mapping- product launches, technological advancements, mergers and expansions • Profiling of companies to evaluate their market shares, strategies, financials and core competencies Table of Contents 1. Market Introduction Market Definition Market Taxonomy 2. Executive Summary Market Overview Market Analysis 3. Market Dynamics Macro-Economic Factors Drivers Restraints Opportunity Analysis Trends 4. Insomnia Treatment Market Size (US$ Mn) Trend Analysis By Drug Type, 2014– 2018 OTC Drugs OTC Sleep Aids OTC Sleep Supplements Prescription Drugs Market Size (US$ Mn) Forecast By Drug Type, 2019–2029 5. Insomnia Treatment Market Size (US$ Mn) Trend Analysis By Distribution Channel, 2014–2018 Hospital Pharmacies Retail Pharmacies e commerce Drug Stores Others 6. North America Insomnia Treatment Market Analysis 2014–2018 and Forecast 2019–2029 Introduction Regional Market Trends U.S. Canada Market Size (US$ Mn) Forecast By Country, 2019–2029 7. Latin America Insomnia Treatment Market Analysis 2014–2018 and Forecast 2019– 2029 Introduction Historical Market Size (US$ Mn) Trend Analysis By Country, 2014–2018 Argentina Brazil Mexico Rest of Latin America Market Size (US$ Mn) Forecast By Country, 2019–2029 8. Europe Insomnia Treatment Market Analysis 2014–2018 and Forecast 2019–2029 Introduction Germany U.K. France Italy Spain Russia Poland Rest of Europe Market Size (US$ Mn) Forecast By Country, 2019–2029 9. Asia Pacific Insomnia Treatment Market Analysis 2014–2018 and Forecast 2019– 2029 Introduction Historical Market Size (US$ Mn) Trend Analysis By Country, 2014–2018 China Japan India Australia and New Zealand ASEAN Rest of Asia Pacific Market Size (US$ Mn) Forecast By Country, 2019–2029 10. Middle East & Africa Insomnia Treatment Market Analysis 2014–2018 and Forecast 2019–2029 Introduction Historical Market Size (US$ Mn) Trend Analysis By Country, 2014–2018 GCC Countries South Africa Rest of MEA Market Size (US$ Mn) Forecast By Country, 2019–2029 11. Competition Analysis Merck & Co. Inc. Natrol, LLC GlaxoSmithKline Plc. Sanofi SA Pfizer Inc. Boehringer Ingelheim International GmbH Mallinckrodt PERNIX Therapeutics Takeda Pharmaceutical Company Limited Sunovion Pharmaceuticals, Inc. Inquire further details about this report at: [email protected] About FutureWise Research: We specialise in high-growth niche markets, assuring flexibility, agility and customised solutions for our clients. Through in-depth market insights and consultancy, we present our clients with the tools they need to be at the forefront of their industry – a position secured for far more than the near future. Contact Us: Company Name: FutureWise Research Contact Person: Vinay Thaploo Email: [email protected] Phone: +44 141 628 9353 / +1 970 279 4295 City: Leeds Country: United Kingdom Website: www.futurewiseresearch.com
© Copyright 2024 Paperzz
